Apoptosis and apoptotic pathway in actinic prurigo by immunohistochemistry by Cuevas González, Juan Carlos et al.
Med Oral Patol Oral Cir Bucal. 2016 Jan 1;21 (1):e53-8.                                                                                                                                                                                Apoptosis in actinic prurigo
e53
Journal section: Oral Medicine and Pathology
Publication Types: Research
Apoptosis and apoptotic pathway in actinic prurigo by immunohistochemistry
Juan-Carlos Cuevas-González 1, María-Elisa Vega-Memíje 2, Francisco-Javier García-Vázquez 3,4, Erika Ro-
dríguez-Lobato 2, José-Eduardo Farfán-Morales 3 
1 Oral Pathology Laboratory, National Autonomous University of Mexico, Mexico City, Mexico
2 Department of Dermatology, Dr. Manuel Gea González General Hospital, Mexico City, Mexico
3 Molecular Pathology Laboratory, National Institute of Pediatrics, Mexico City, Mexico
4 Southern associated Pathologists “Specialists in pathology laboratories” Mexico City, Mexico 
Correspondence:
Department of Dermatology
Dr. Manuel Gea González General Hospital
Calzada de Tlalpan 4800
Sección XVI Delegación Tlalpan
México, D.F. C.P 14080 
elisavega50@gmail.com
Received: 10/04/2015
Accepted: 07/08/2015
Abstract
Background: Actinic prurigo (AP) is an idiopathic photodermatosis, this entity requires exposure to UV-B and 
-A to develop lesions.  Apoptosis is a physiological death program that can be initiated by a permanently active 
mechanism (extrinsic pathway) or irreparable damage (intrinsic pathway).
Material and methods: Descriptive study, the sample size comprised 64 paraffin blocks of tissue with a diagnosis 
of AP. In H&E-stained slides, the diagnosis of AP was corroborated, and 1-µm-thick sections were processed for 
immunohistochemistry (IHC). A database was constructed with SPSS version 20, Inc., Chicago, IL, USA, and 
descriptive statistics were analyzed by X2 test and comparison of means.
Results: A total of 64 cases were processed, of which 40 (62.5%) were cheilitis AP and 24 (37.5%) were AP in 
the skin. Of the 40 cheilitis samples, 27 were positive for Bcl-2 and caspase 3 (67.5%), p53 was expressed in 30 
(75%). Of the skin lesions, p53 and caspase 3 were expressed in 18 of 24 cases (75%), and 13 were positive for 
Bcl-2 (54%). 
Conclusions: We propose that apoptosis is the last step in the type IV subtype a-b hypersensitivity response-
activation of the intrinsic pathway indicates that external factors, such as UV-A and -B are the trigger.
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Introduction
Actinic prurigo (AP) is an idiopathic photodermatosis, 
the first manifestations of which occur during child-
hood, and predominantly affects women. With regard 
to genetic susceptibility, a strong link has been reported 
between AP and human leukocyte antigen (HLA), par-
ticularly with the HLA-DR4, (1) allele, which varies be-
tween populations. In Mexico, 90% to 92.8% of patients 
with AP have this allele (2-4). HLA-DRB1*0407 (5,6) is 
the most common subtype (60% to 80%) (2-4).
AP is characterized by symmetrical and bilateral lesions 
in sun-exposed areas, such as the face, neck, trunk, up-
per and lower extremities, lips, and conjunctiva. As a 
photodermatosis, this entity requires exposure to UV-B 
and -A to develop lesions and presents clinically as 
macules, papules, excoriations, serohematic crusts, ar-
eas of lichenification, scarring, and residual hypo- or 
hyperpigmentation (2,6-8). Based on their histological 
characteristics, the skin lesions can be considered hy-
perkeratosis; parakeratosis; acanthosis; thickening of 
the basal lamina; perivascular inflammatory infiltrate; 
and nodular lymphocyte formations, eosinophils, and 
mast cells. In cheilitis, hyperkeratosis, acanthosis, spon-
giosis and vacuolization of the basal layer, eosinophils, 
melanophages, angiogenesis, edema, and formation of 
lymphoid follicles are observed, all of which pathogno-
monic of the disease (9).
The pathophysiology of AP has been examined with re-
gard to immune and inflammatory responses and has 
been proposed as a type IV, subtype b hypersensitiv-
ity reaction; the inflammatory infiltrate comprises pri-
marily mainly CD45RO, interleukin-2, and T cells (8). 
Moncada studied 16 patients with AP and found that T 
cell levels increased in peripheral blood versus controls, 
suggesting that an abnormal immune response causes 
the tissue damage in these patients (10).
In this condition, a reaction with type IV subtype “a” 
component entails a Th1 response in which macrophag-
es are activated by secreting large amounts of interferon 
gamma and direct the production of complement-fixing 
antibodies.  
In AP, TNF-α is expressed primarily mainly in kerati-
nocytes in the suprabasal layer. UV-B light stimulates 
the production of TNF-α in keratinocytes, which rises 
to concentrations that can induce necrosis. In inflamma-
tory diseases, TNF-α, in combination with interferon 
gamma, upregulates adhesion molecules on keratino-
cytes, as reported by researchers at our hospital, who 
measured syndecan-1 and E-cadherin expression in 
epithelial tissues with AP, indicating that although this 
disease has a strong inflammatory component, the ex-
pression of adhesion molecules is preserved. Another 
function of TNF-α is to stimulate fibroblast proliferation 
and capillary formation. The involvement of TNF-α has 
been demonstrated indirectly, based on the clinical im-
provement that occurs on inhibition by thalidomide (9).
In addition to a Th2 response, which develops in the 
type IV response, subtype “B” cells produce cytokines, 
such as IL3, IL4, IL5, and GM-CSF, of which IL4 is 
crucial for the activation of IgE (8).
We reported enhanced serum IgE levels in patients with 
AP who had moderate to severe injuries by (Access to-
tal IGE), compared with those with minor injuries, in 
whom the levels were within the normal range. Our 
working group identified tissue with AP that harbored 
mast cells and eosinophils by immunohistochemistry.
Thus, with regard to the components of the subtype “a” 
and “b” type IV responses, apoptosis occurs after the 
activation of cells and cytokines-a process that has not 
been demonstrated in the pathophysiology of AP. 
Apoptosis is programmed cell death, in which a several 
enzymatic reactions are activated, leading to disorgani-
zation of protein networks and subsequent damage to 
DNA. In the initial phase of apoptosis, membrane integ-
rity is maintained, preventing intracellular components 
from being released and tissue from incurring damage 
directly (9).
In this study the aim was evaluate the activation of ap-
optosis in AP and the apoptotic pathways that are in-
volved.
Material and Methods
This descriptive study was conducted in the Depart-
ment of Dermatology, General Hospital Dr. Manuel 
Gea González and was approved by the ethics commit-
tee and research, patients signed an informed consent, 
the sample size comprised 64 paraffin blocks of tissue 
with a diagnosis of AP-40 corresponding to AP in the 
lip and 24 in the skin.
In H&E-stained slides, the diagnosis of AP was corrob-
orated by 2 examiners, and 1- µm-thick sections were 
processed for immunohistochemistry (IHC). The slides 
were deparaffinized and rehydrated, antigen retrieval 
was performed with 0.1% sodium citrate, pH 6.2, en-
dogenous peroxidase was inactivated with 0.9% hydro-
gen peroxide, and the slides were washed in distilled 
water and allowed to stand for 5 minutes in phosphate-
buffered saline (PBS).
The tissue sections were incubated for 45 minutes with 
the following antibodies: bcl-2 (1:100, Dako clone 124), 
p53 (1:100, Dako clone DO-7), caspase 3 (1:100, Biocare), 
Bax (1:100, Dako), and Fas-CD-95 (1:100, Santa Cruz 
clone C-20). Then, secondary anti-mouse or -rabbit and 
streptavidin/peroxidase were added sequentially for 30 
minutes each. The reaction was visualized with diami-
nobenzidine (Dako) and stained with Hill’s hematoxylin.
The immunoreactivity as evaluated in 2 phases: first by 
2 evaluators to determine the positive histological sites 
and second to measure the intensity of the reactions 
semiquantitatively using Image Lab, version 2.0. Four 
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photos (400x) were taken for each positive case, for 
which the optical density was measured and expressed 
as the mean for each case. If the optical density was 40 
or less, positivity was defined as mild; between 40 and 
80 was considered moderate, and values of 81 or more 
were severe. A database was constructed with SPSS, 
version 20, and descriptive statistics were analyzed by 
X2 test and comparison of means.
Results
A total of 64 cases were processed, of which 40 (62.5%) 
were cheilitis AP and 24 (37.5%) were AP in the skin. 
(Table 1) Of the 40 cheilitis samples, 27 were positive 
Expression of apoptotic antibodies in cheilitis AP 
Caspase 3 Bcl-2 p53
 + X2 P + X2 P + X2 P
Basal layer 14 10.370 .001 0 0 0 30 31.111 .000 
Stratum spinosum 11 7.305 .007 0 0 0 0 0 0 
Granular layer 10 6.420 .011 0 0 0 0 0 0 
Apoptotic keratinocytes 6 3.339 .065 7 6.271 .012 1 .342 .559 
Melanocytes 6 3.339 .065 7 6.271 .012 1 .342 .559 
Follicle center 12 8.254 .004 1 .048 .826 0 0 0 
Periphery of the follicle 0 0 0 16 13.195 .000 0 0 0 
Perivascular infiltrate  27 5.591 .018 27 13.195 .000 30 31.111 .000 
Diffuse lymphocyte 9 5.591 .018 9 5.763 .016 0 0 0 
Macrophages 9 5.591 .018 4 3.285 .070 0 0 0 
Eosinophils 14 10.370 .001 6 5.217 .022 0 0 0 
           Expression of apoptotic antibodies in skin lesions in AP 
Caspase 3 Bcl-2 p53
 + X2 P + X2 P + X2 P
Basal layer 18 9.455 .002 0 0 0 18 24.00 .000 
Stratum spinosum 18 9.455 .002 0 0 0 0 0 0 
Granular layer 11 6.769 .009 0 0 0 0 0 0 
Apoptotic keratinocytes 0 0 0 6 6.769 .009 0 0 0 
Melanocytes 0 0 0 8 10.154 .001 0 0 0 
Nodular lymphocytic infiltrate 2 .727 .394 0 0 0 0 0 0 
Perivascular infiltrate 9 4.800 .028 13 6.769 .009 1 .348 .555 
Diffuse lymphocyte 0 0 0 9 12.185 .000 0 0 0 
Macrophages 7 3.294 .070 3 2.901 .098 0 0 0 
Eosinophils 6 2.667 .102 4 4.02 .044 0 0 0 
Table 1. Immunohistochemical analysis in cheilitis AP and skin lesions.
for Bcl-2 and caspase 3 (67.5%), p53 was expressed in 30 
(75%), and Bax was present in 1 (2.5%); none was posi-
tive for Fas [positivity was limited to internal controls 
(melanocytes and apoptotic keratinocytes)]. (Fig. 1)
Of the skin lesions, p53 and caspase 3 were expressed 
in 18 of 24 cases (75%), and 13 were positive for Bcl-2 
(54%). None was positive for Bax or Fas. (Figs. 2,3).
The mean expression levels for caspase 3, bcl-2, and p53 
in the cheilitis samples were 66.61, 116.71, and 38.71, 
respectively, versus 59.34, 68.54, and 32.71 for skin le-
sions; no significant differences were noted between 
these values (Table 2).
Discussion
Apoptosis is a physiological death program that can be 
initiated in 2 ways. The extrinsic pathway, involves a 
death receptor (TNF type 1) and Fas (CD95) and their 
ligands, TNF and Fas ligand (Fas L), respectively. In the 
intrinsic pathway, the cell suffers irreparable damage, 
and apoptosis is initiated by exposure to antigens, such 
as bacteria, toxins, and free radicals, and solar radiation 
and mediated by inhibitors, such as Bcl-2 and bcl-XL, 
and facilitators, such as Bax and Bad (8,11). 
Signaling through Fas leads to apoptosis, requiring 
the binding of Fas to anti-Fas or cells that expressing 
Fas L or soluble Fas L. Fas associates with MORT1 (or 
FADD-Fas-associating protein with death domain) and 
RIP (receptor-interacting protein). Then, the Fas-FADD 
complex binds to MACH, activating the latter. MACH 
is a proteolytic enzyme that belongs to the family of 
caspases (caspase-8) that trigger apoptosis (12-14).  
We observed Fas positivity in apoptotic keratinocytes 
and melanocytes in cheilitis lesions and skin lesions, al-
though this positivity is considered to be normal (inter-
nal control), being induced by the inflammatory infil-
trate. There were no Fas-positive cases in characteristic 
AP histological sites. Thus, we infer that the extrinsic 
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pathway of apoptosis is not active in the pathophysiol-
ogy of AP.
Bax is a proapoptotic member of the Bcl-2 family, 
which regulates intrinsic apoptosis signaling (15). It is 
expressed in the cytoplasm of cells in an inactive form 
and is stimulated in the early stages of apoptosis, asso-
ciating with mitochondria through unidentified mecha-
nisms and inducing conformational changes that trigger 
programmed cell death (16). In this study, we found in 
one Bax-positive case of cheilitis.
Bcl-2 suppresses apoptosis by 2 mechanisms: direct ac-
tion against mitochondria to prevent increased perme-
ability and through interactions with other proteins. In 
other cases, Bcl-2 can also suppress apoptosis by fix-
ing cytosolic proteins and abducting in the mitochon-
drial membrane (8). In our cheilitis AP samples, we ob-
served significant positivity with anti-Bcl-2 (periphery 
of lymphoid follicles), reflecting an attempt to suppress 
apoptosis at this site. Other sites of antibody positiv-
ity in both lesion types were the perivascular infiltrate, 
diffuse lymphocytes, keratinocytes, melanocytes, and 
macrophages. Bax and Bcl-2 should be interpreted 
jointly-Bax overexpression in cells accelerates apopto-
sis in response to a death signal, and in contrast, when 
Bcl2 is overexpressed, cell death is suppressed. 
Activation of caspase 3 is a hallmark of apoptosis and 
can be used to quantify the activation and inhibition of 
the cell death cascade. Cells become more susceptible 
to staurosporine (protein kinase inhibitor) in a specific 
phase of the cell cycle, which leads to cell death (17).
There are 2 major groups of caspases: initiating and ex-
ecuting. Initiator caspases are activated by autoprote-
olysis when they translocate to specific compartments 
or through adapters/drivers. Executing caspases are 
activated by specific cuts that are induced by initiator 
caspases. These proteases mediate the final cuts in sub-
strates, causing the typical morphology in apoptosis, 
including signal proteins, DNA repair enzymes, struc-
tural proteins, and transcription factors (18), caspase 3 
is the executor of apoptosis.
Fig. 1. A, B, C, and D. (100x) Cytoplasmic reaction of Bcl-2 anti-
body in peripheral lymphocytes forming the lymphoid follicle in AP 
cheilitis and in diffuse lymphocytic infiltrate, indicating an attempt 
to suppress apoptosis in this site.
Fig. 2. A and B. (100x) Caspase 3, positivity in the central cell 
of the lymphoid follicle in AP cheilitis. C. (400x) Reaction in the 
basal layer of skin lesions D. (400x) Perivascular lymphocytic in-
filtrate. Caspase 3 positivity was nuclear in epithelial cells and 
cytoplasmic in inflammatory cells; positivity indicates the pres-
ence of apoptosis.
Fig. 3. A and B. (400x) Nuclear positivity in basal layer of p53 in AP cheilitis and 
skin lesions. In cheilitis, the positivity was in the perivascular lymphocytic infil-
trate.
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In our tissue samples, caspase 3 expression was nuclear 
in epithelial cells and cytoplasmic in connective tissue 
cells. In lymphoid follicles, it was expressed signifi-
cantly in central lymphocytes, indicating the onset of 
the cell death cascade. Bcl-2 was positive in peripheral 
lymphocytes in the follicle, thus, we conclude that ap-
optosis was initiated in B lymphocytes and inhibited in 
T lymphocytes.
Caspase 3 was expressed in diffuse and perivascular 
cells, in the basal layer of the epithelium (where mito-
sis is frequent), and in the stratum spinosum, indicating 
that the apoptosis was activated in different histopatho-
logical sites.
p53 protein mediates apoptosis in response to DNA-
damaging agents. Typically, p53 is a transcription fac-
tor that governs the gene expression cluster that arrests 
the cell cycle or initiates the apoptotic process (19).  We 
noted p53 positivity in AP lesions in the skin and lip.
Conclusion
Apoptosis was observed in AP, which will help us un-
derstand its pathophysiology. We propose that apoptosis 
is the last step in the type IV subtype a-b hypersensi-
tivity response-activation of the intrinsic pathway in-
dicates that external factors, such as UV-A and -B are 
the trigger. 
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